Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is environmental carcinogenesis modulated by host polymorphism?

J R Idle1

  • 1Department of Pharmacological Sciences, Medical School, Newcastle upon Tyne, Great Britain.

Mutation Research
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.

Journal of viral hepatitis·2014
Same author

Miotic action of tramadol is determined by CYP2D6 genotype.

Physiological research·2006
Same author

Christmas gingerbread (Lebkuchen) and Christmas cheer--review of the potential role of mood elevating amphetamine-like compounds formed in vivo and in furno.

Prague medical report·2005
Same author

Early glucose and methylene blue are effective against unripe ackee apple (Blighia sapida) poisoning in mice.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2004
Same author

Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.

The pharmacogenomics journal·2003
Same author

The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.

Molecular pharmacology·2001

Genetic factors, including CYP1A1, CYP2D6, GST1, and N-acetyltransferase (NAT) genes, interact with lifestyle and environmental exposures to influence cancer risk. Understanding these gene-environment interactions is key to personalized cancer prevention strategies.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Environmental Health

Background:

  • Individual cancer risk is influenced by a complex interplay of genetic predisposition and environmental factors such as tobacco smoking, alcohol consumption, diet, and occupation.
  • Specific gene variants, including those in CYP1A1, CYP2D6, GST1, and N-acetyltransferase (NAT), are associated with significantly elevated cancer risks.
  • The cloning of the NAT gene is pending, highlighting ongoing research in this field.

Purpose of the Study:

  • To explore the synergistic effects of genetic polymorphisms and environmental exposures on cancer susceptibility.
  • To identify specific gene-gene interactions that may cooperatively increase cancer risk.
  • To highlight the potential of molecular genetics in predicting individual cancer risk.

Main Methods:

Related Experiment Videos

  • Review of existing literature on gene-environment interactions in cancer.
  • Analysis of known gene variants (CYP1A1, CYP2D6, GST1, NAT) and their association with cancer phenotypes.
  • Discussion of potential additive or multiplicative risks from combined genotypes.
  • Consideration of molecular screening methods like PCR for susceptibility assessment.

Main Results:

  • Certain gene variants (CYP1A1, CYP2D6, GST1, NAT) confer elevated cancer risks.
  • Cooperative interactions between genes like CYP1A1, CYP2D6, and GST1 may increase the risk of bronchogenic carcinoma in smokers.
  • Interactions between CYP2D6 and NAT genotypes are implicated in bladder cancer development.

Conclusions:

  • Genetic host factors significantly modulate cancer risk in conjunction with environmental exposures.
  • Understanding gene-gene and gene-environment interactions is crucial for personalized cancer risk assessment.
  • Molecular screening holds promise for identifying individuals at high risk, enabling targeted preventive measures.